These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12823645)

  • 1. Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women.
    Duschek EJ; Stehouwer CD; de Valk-de Roo GW; Schalkwijk CG; Lambert J; Netelenbos C
    J Intern Med; 2003 Jul; 254(1):85-94. PubMed ID: 12823645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease.
    Griffiths KA; Sader MA; Skilton MR; Harmer JA; Celermajer DS
    J Am Coll Cardiol; 2003 Aug; 42(4):698-704. PubMed ID: 12932604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
    Cerquetani E; Vitale C; Mercuro G; Fini M; Zoncu S; Rosano GM
    Gynecol Endocrinol; 2004 Jun; 18(6):291-8. PubMed ID: 15497491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene and endothelial function in healthy postmenopausal women.
    Sarrel PM; Nawaz H; Chan W; Fuchs M; Katz DL
    Am J Obstet Gynecol; 2003 Feb; 188(2):304-9. PubMed ID: 12592230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial function and menopause: effects of raloxifene administration.
    Colacurci N; Manzella D; Fornaro F; Carbonella M; Paolisso G
    J Clin Endocrinol Metab; 2003 May; 88(5):2135-40. PubMed ID: 12727966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women.
    Ceresini G; Marchini L; Rebecchi I; Morganti S; Bertone L; Montanari I; Bacchi-Modena A; Sgarabotto M; Baldini M; Denti L; Ablondi F; Ceda GP; Valenti G
    Atherosclerosis; 2003 Mar; 167(1):121-7. PubMed ID: 12618276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women.
    Giltay EJ; Duschek EJ; Katan MB; Zock PL; Neele SJ; Netelenbos JC
    J Endocrinol; 2004 Sep; 182(3):399-408. PubMed ID: 15350182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
    Teerlink T; Neele SJ; de Jong S; Netelenbos JC; Stehouwer CD
    Clin Sci (Lond); 2003 Jul; 105(1):67-71. PubMed ID: 12625833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Koizumi A; Kanai H; Araki Y; Itoh T; Iwasaki T; Sawada Y; Saito Y; Kumakura H; Takayama Y; Kanda T; Murakami M; Sakamaki T; Kurabayashi M
    Int Heart J; 2010 Jan; 51(1):60-7. PubMed ID: 20145354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene improves the ovariectomy-induced impairment in endothelium-dependent vasodilation.
    Takahashi K; Mori-Abe A; Takata K; Ohta T; Kawagoe J; Tsutsumi S; Ohmichi M; Kurachi H
    Menopause; 2007; 14(4):656-61. PubMed ID: 17242632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women.
    Cagnacci A; Arangino S; Renzi A; Zanni AL; Volpe A
    Am J Obstet Gynecol; 2003 Feb; 188(2):313-7. PubMed ID: 12592232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women.
    Katz DL; Evans MA; Njike VY; Hoxley ML; Nawaz H; Comerford BP; Sarrel PM
    Climacteric; 2007 Dec; 10(6):500-7. PubMed ID: 18049943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women.
    Mijatovic V; Netelenbos C; van der Mooren MJ; de Valk-de Roo GW; Jakobs C; Kenemans P
    Fertil Steril; 1998 Dec; 70(6):1085-9. PubMed ID: 9848300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
    Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of raloxifene and simvastatin on plasma lipids and endothelium.
    Sbarouni E; Flevari P; Kroupis C; Kyriakides ZS; Koniavitou K; Kremastinos DT
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):319-23. PubMed ID: 14618093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
    Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
    Duschek EJ; de Valk-de Roo GW; Gooren LJ; Netelenbos C
    Fertil Steril; 2004 Aug; 82(2):384-90. PubMed ID: 15302288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
    Usall J; Huerta-Ramos E; Labad J; Cobo J; Núñez C; Creus M; Parés GG; Cuadras D; Franco J; Miquel E; Reyes JC; Roca M;
    Schizophr Bull; 2016 Mar; 42(2):309-17. PubMed ID: 26591005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.